Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Orphan drug reverses vision loss in patients with Leber's hereditary optic neuropathy

April 30, 2012

Advanced Cell Technology clear to continue Stargardt's macular dystrophy trials

April 27, 2012

Alimera announces first marketing authorization for Iluvien in E.U.

April 25, 2012

Scripps Research receives grant to develop new eye disease treatments

April 24, 2012

Senju Pharmaceutical plans new release of ophthalmic solution

April 20, 2012

ThromboGenics resubmits BLA for ocriplasmin

April 17, 2012

MacuCLEAR to advance MC-1101 to phase III development

April 12, 2012

Omeros begins enrollment in second phase III OMS-302 trial

April 11, 2012

Preclinical studies demonstrate small molecule's efficacy to treat anterior uveitis

April 10, 2012

DARPin-based VEGF inhibitor completes phase IIa trial

April 10, 2012

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 11, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 11, 2025
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...
Magnet, Eli Lilly sign $1.25B molecular glue deal for oncology
BioWorld
About 17 months after emerging from stealth with its Trueglue discovery platform, Magnet Biomedicine Inc. has joined with Eli Lilly and Co. to discover, develop...